$Moderna (MRNA.US)$ Vaccine maker Moderna said on Monday tha...

$Moderna(MRNA.US)$ Vaccine maker Moderna said on Monday that its COVID-19 booster shot protected against the fast-spreading omicron strain in laboratory tests. Moderna also said that development of a vaccine for Omicron would continue and that it was expected to enter clinical trials in early 2022. Moderna shares rose more than 6.5% in pre-market trading after the announcement.